25 XP   0   0   10

Organoclick AB
Buy, Hold or Sell?

Let's analyse Organoclick together

PenkeI guess you are interested in Organoclick AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Organoclick AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Organoclick AB

I send you an email if I find something interesting about Organoclick AB.

Quick analysis of Organoclick (30 sec.)










What can you expect buying and holding a share of Organoclick? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.55
Expected worth in 1 year
kr0.40
How sure are you?
17.5%

+ What do you gain per year?

Total Gains per Share
kr-0.14
Return On Investment
-4.6%

For what price can you sell your share?

Current Price per Share
kr3.15
Expected price per share
kr3.12 - kr3.88
How sure are you?
50%

1. Valuation of Organoclick (5 min.)




Live pricePrice per Share (EOD)

kr3.15

Intrinsic Value Per Share

kr-1.64 - kr-0.98

Total Value Per Share

kr-1.09 - kr-0.43

2. Growth of Organoclick (5 min.)




Is Organoclick growing?

Current yearPrevious yearGrowGrow %
How rich?$4.8m$8.1m-$2.5m-44.7%

How much money is Organoclick making?

Current yearPrevious yearGrowGrow %
Making money-$354.2k-$948.9k$594.6k167.8%
Net Profit Margin-12.3%-42.1%--

How much money comes from the company's main activities?

3. Financial Health of Organoclick (5 min.)




4. Comparing to competitors in the Specialty Chemicals industry (5 min.)




  Industry Rankings (Specialty Chemicals)  


Richest
#525 / 562

Most Revenue
#521 / 562

Most Profit
#437 / 562

Most Efficient
#501 / 562

What can you expect buying and holding a share of Organoclick? (5 min.)

Welcome investor! Organoclick's management wants to use your money to grow the business. In return you get a share of Organoclick.

What can you expect buying and holding a share of Organoclick?

First you should know what it really means to hold a share of Organoclick. And how you can make/lose money.

Speculation

The Price per Share of Organoclick is kr3.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Organoclick.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Organoclick, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.55. Based on the TTM, the Book Value Change Per Share is kr-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Organoclick.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.01-0.2%0.00-0.1%-0.01-0.3%-0.01-0.2%-0.01-0.2%
Usd Book Value Change Per Share-0.01-0.2%0.00-0.1%-0.01-0.3%0.000.0%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.2%0.00-0.1%-0.01-0.3%0.000.0%0.000.0%
Usd Price Per Share0.29-0.35-0.32-0.53-0.49-
Price to Earnings Ratio-9.76--42.52--10.27--33.15--28.06-
Price-to-Total Gains Ratio-40.68--226.25--58.00--159.04-1,309.29-
Price to Book Ratio5.83-6.06-3.84-7.34-8.75-
Price-to-Total Gains Ratio-40.68--226.25--58.00--159.04-1,309.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.28728
Number of shares3480
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (3480 shares)-11.463.01
Gains per Year (3480 shares)-45.8512.06
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-46-560122
20-92-10202414
30-138-14803626
40-183-19404838
50-229-24006050
60-275-28607262
70-321-33208474
80-367-37809686
90-413-424010998
100-458-4700121110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.041.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%7.031.02.017.5%8.031.02.019.5%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.041.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%7.031.02.017.5%8.031.02.019.5%

Fundamentals of Organoclick

About Organoclick AB

OrganoClick AB (publ), a material and chemical technology company, develops, manufactures, and markets fiber-based materials and biobased chemical products for the treatment of wood, technical textile and nonwoven, and bio composites in Sweden. The company provides OrganoWood, a wood preservative technology and wood preservative that gives wood enhanced durability against rot and fire primarily for construction companies and consumers; OrganoTex, a biodegradable durable water repellent technology and textile treatment that makes textile products water repellent, as well as offers shoe and clothes care products; and OrganoComp, a biobased plastic-free and degradable bio-composite used for make 3D-shaped objects that replaces hard plastic materials, such as polypropylene. It also offers consumer products, including a range of maintenance and cleaning products for wood, facades, roofs, and terraces, as well as for car care under the BIOkleen name; OC-BioBinder, a biobased, plastic-free, and degradable binder used by industrial customers as a replacement for plastic binders in nonwoven and technical textiles; and OC-AquaSil Tex, a biodegradable hydrophobing product used to replace PFAS in nonwovens, specialty papers, and technical textiles. The company was founded in 2006 and is headquartered in Täby, Sweden.

Fundamental data was last updated by Penke on 2024-04-02 20:51:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Organoclick AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Organoclick earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Organoclick to the Specialty Chemicals industry mean.
  • A Net Profit Margin of -28.6% means that kr-0.29 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Organoclick AB:

  • The MRQ is -28.6%. The company is making a huge loss. -2
  • The TTM is -12.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-28.6%TTM-12.3%-16.3%
TTM-12.3%YOY-42.1%+29.8%
TTM-12.3%5Y-29.7%+17.4%
5Y-29.7%10Y-52.7%+23.1%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-28.6%4.0%-32.6%
TTM-12.3%4.4%-16.7%
YOY-42.1%6.5%-48.6%
5Y-29.7%6.2%-35.9%
10Y-52.7%6.0%-58.7%
1.1.2. Return on Assets

Shows how efficient Organoclick is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Organoclick to the Specialty Chemicals industry mean.
  • -5.3% Return on Assets means that Organoclick generated kr-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Organoclick AB:

  • The MRQ is -5.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.3%TTM-2.5%-2.8%
TTM-2.5%YOY-6.0%+3.5%
TTM-2.5%5Y-3.9%+1.4%
5Y-3.9%10Y-6.4%+2.5%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.3%1.6%-6.9%
TTM-2.5%1.8%-4.3%
YOY-6.0%2.6%-8.6%
5Y-3.9%2.4%-6.3%
10Y-6.4%2.6%-9.0%
1.1.3. Return on Equity

Shows how efficient Organoclick is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Organoclick to the Specialty Chemicals industry mean.
  • -17.9% Return on Equity means Organoclick generated kr-0.18 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Organoclick AB:

  • The MRQ is -17.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.9%TTM-8.0%-9.9%
TTM-8.0%YOY-14.9%+6.9%
TTM-8.0%5Y-12.3%+4.3%
5Y-12.3%10Y-19.8%+7.5%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.9%3.3%-21.2%
TTM-8.0%3.6%-11.6%
YOY-14.9%5.1%-20.0%
5Y-12.3%4.6%-16.9%
10Y-19.8%4.9%-24.7%

1.2. Operating Efficiency of Organoclick AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Organoclick is operating .

  • Measures how much profit Organoclick makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Organoclick to the Specialty Chemicals industry mean.
  • An Operating Margin of -22.1% means the company generated kr-0.22  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Organoclick AB:

  • The MRQ is -22.1%. The company is operating very inefficient. -2
  • The TTM is -7.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-22.1%TTM-7.7%-14.4%
TTM-7.7%YOY-39.2%+31.5%
TTM-7.7%5Y-26.4%+18.6%
5Y-26.4%10Y-50.2%+23.8%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.1%7.5%-29.6%
TTM-7.7%6.0%-13.7%
YOY-39.2%8.5%-47.7%
5Y-26.4%8.4%-34.8%
10Y-50.2%8.2%-58.4%
1.2.2. Operating Ratio

Measures how efficient Organoclick is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • An Operation Ratio of 1.22 means that the operating costs are kr1.22 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Organoclick AB:

  • The MRQ is 1.221. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.076. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.221TTM1.076+0.145
TTM1.076YOY1.420-0.345
TTM1.0765Y1.256-0.181
5Y1.25610Y1.462-0.206
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2211.548-0.327
TTM1.0761.548-0.472
YOY1.4201.436-0.016
5Y1.2561.453-0.197
10Y1.4621.301+0.161

1.3. Liquidity of Organoclick AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Organoclick is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Current Ratio of 0.81 means the company has kr0.81 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Organoclick AB:

  • The MRQ is 0.814. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.921. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.814TTM0.921-0.107
TTM0.921YOY1.168-0.247
TTM0.9215Y1.319-0.398
5Y1.31910Y1.525-0.206
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8141.831-1.017
TTM0.9211.893-0.972
YOY1.1681.928-0.760
5Y1.3191.922-0.603
10Y1.5251.825-0.300
1.3.2. Quick Ratio

Measures if Organoclick is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Organoclick to the Specialty Chemicals industry mean.
  • A Quick Ratio of 0.35 means the company can pay off kr0.35 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Organoclick AB:

  • The MRQ is 0.350. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.469. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.350TTM0.469-0.119
TTM0.469YOY0.568-0.099
TTM0.4695Y0.775-0.306
5Y0.77510Y0.853-0.078
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3500.809-0.459
TTM0.4690.845-0.376
YOY0.5680.933-0.365
5Y0.7751.022-0.247
10Y0.8531.031-0.178

1.4. Solvency of Organoclick AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Organoclick assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Organoclick to Specialty Chemicals industry mean.
  • A Debt to Asset Ratio of 0.65 means that Organoclick assets are financed with 64.6% credit (debt) and the remaining percentage (100% - 64.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Organoclick AB:

  • The MRQ is 0.646. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.627. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.646TTM0.627+0.018
TTM0.627YOY0.509+0.119
TTM0.6275Y0.520+0.107
5Y0.52010Y0.482+0.038
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6460.422+0.224
TTM0.6270.422+0.205
YOY0.5090.421+0.088
5Y0.5200.430+0.090
10Y0.4820.438+0.044
1.4.2. Debt to Equity Ratio

Measures if Organoclick is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Organoclick to the Specialty Chemicals industry mean.
  • A Debt to Equity ratio of 218.3% means that company has kr2.18 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Organoclick AB:

  • The MRQ is 2.183. The company is just not able to pay all its debts with equity.
  • The TTM is 1.975. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.183TTM1.975+0.209
TTM1.975YOY1.180+0.795
TTM1.9755Y2.374-0.400
5Y2.37410Y2.006+0.368
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1830.741+1.442
TTM1.9750.741+1.234
YOY1.1800.737+0.443
5Y2.3740.795+1.579
10Y2.0060.845+1.161

2. Market Valuation of Organoclick AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Organoclick generates.

  • Above 15 is considered overpriced but always compare Organoclick to the Specialty Chemicals industry mean.
  • A PE ratio of -9.76 means the investor is paying kr-9.76 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Organoclick AB:

  • The EOD is -9.669. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.761. Based on the earnings, the company is expensive. -2
  • The TTM is -42.516. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.669MRQ-9.761+0.092
MRQ-9.761TTM-42.516+32.755
TTM-42.516YOY-10.275-32.241
TTM-42.5165Y-33.154-9.361
5Y-33.15410Y-28.062-5.092
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD-9.66915.438-25.107
MRQ-9.76115.310-25.071
TTM-42.51615.895-58.411
YOY-10.27517.925-28.200
5Y-33.15420.070-53.224
10Y-28.06223.171-51.233
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Organoclick AB:

  • The EOD is 22.026. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 22.236. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -47.717. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD22.026MRQ22.236-0.210
MRQ22.236TTM-47.717+69.953
TTM-47.717YOY-31.866-15.850
TTM-47.7175Y13.601-61.317
5Y13.60110Y-6.016+19.616
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD22.0264.479+17.547
MRQ22.2363.723+18.513
TTM-47.7171.853-49.570
YOY-31.866-2.346-29.520
5Y13.6012.994+10.607
10Y-6.0163.247-9.263
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Organoclick is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 5.83 means the investor is paying kr5.83 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Organoclick AB:

  • The EOD is 5.777. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.832. Based on the equity, the company is overpriced. -1
  • The TTM is 6.057. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD5.777MRQ5.832-0.055
MRQ5.832TTM6.057-0.224
TTM6.057YOY3.845+2.212
TTM6.0575Y7.342-1.285
5Y7.34210Y8.753-1.411
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD5.7771.688+4.089
MRQ5.8321.833+3.999
TTM6.0571.845+4.212
YOY3.8452.332+1.513
5Y7.3422.344+4.998
10Y8.7532.622+6.131
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Organoclick AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.078-0.036-54%-0.103+31%0.009-923%0.008-1064%
Book Value Per Share--0.5450.629-13%0.910-40%0.866-37%0.655-17%
Current Ratio--0.8140.921-12%1.168-30%1.319-38%1.525-47%
Debt To Asset Ratio--0.6460.627+3%0.509+27%0.520+24%0.482+34%
Debt To Equity Ratio--2.1831.975+11%1.180+85%2.374-8%2.006+9%
Dividend Per Share----0%-0%-0%-0%
Eps---0.081-0.040-51%-0.113+39%-0.070-14%-0.064-21%
Free Cash Flow Per Share--0.036-0.021+158%-0.090+352%-0.065+282%-0.071+298%
Free Cash Flow To Equity Per Share--0.011-0.011+203%-0.066+693%-0.001+110%-0.002+114%
Gross Profit Margin--1.0003.974-75%1.914-48%2.566-61%1.929-48%
Intrinsic Value_10Y_max---0.978--------
Intrinsic Value_10Y_min---1.637--------
Intrinsic Value_1Y_max---0.256--------
Intrinsic Value_1Y_min---0.300--------
Intrinsic Value_3Y_max---0.650--------
Intrinsic Value_3Y_min---0.790--------
Intrinsic Value_5Y_max---0.897--------
Intrinsic Value_5Y_min---1.152--------
Market Cap308542500.000-1%311481000.000374046562.500-17%343192312.500-9%571930050.000-46%529125900.000-41%
Net Profit Margin---0.286-0.123-57%-0.421+47%-0.297+4%-0.527+84%
Operating Margin---0.221-0.077-65%-0.392+77%-0.264+19%-0.502+127%
Operating Ratio--1.2211.076+14%1.420-14%1.256-3%1.462-16%
Pb Ratio5.777-1%5.8326.057-4%3.845+52%7.342-21%8.753-33%
Pe Ratio-9.669+1%-9.761-42.516+336%-10.275+5%-33.154+240%-28.062+187%
Price Per Share3.150-1%3.1803.819-17%3.504-9%5.839-46%5.402-41%
Price To Free Cash Flow Ratio22.026-1%22.236-47.717+315%-31.866+243%13.601+63%-6.016+127%
Price To Total Gains Ratio-40.301+1%-40.685-226.250+456%-58.004+43%-159.035+291%1309.292-103%
Quick Ratio--0.3500.469-25%0.568-38%0.775-55%0.853-59%
Return On Assets---0.053-0.025-53%-0.060+13%-0.039-26%-0.064+22%
Return On Equity---0.179-0.080-55%-0.149-17%-0.123-31%-0.198+11%
Total Gains Per Share---0.078-0.036-54%-0.103+31%0.009-923%0.008-1064%
Usd Book Value--4870718.4005617418.400-13%8128610.400-40%7739551.200-37%5849794.664-17%
Usd Book Value Change Per Share---0.007-0.003-54%-0.009+31%0.001-923%0.001-1064%
Usd Book Value Per Share--0.0500.057-13%0.083-40%0.079-37%0.060-17%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.007-0.004-51%-0.010+39%-0.006-14%-0.006-21%
Usd Free Cash Flow--319382.400-184201.200+158%-806002.800+352%-579918.000+282%-631502.065+298%
Usd Free Cash Flow Per Share--0.003-0.002+158%-0.008+352%-0.006+282%-0.006+298%
Usd Free Cash Flow To Equity Per Share--0.001-0.001+203%-0.006+693%0.000+110%0.000+114%
Usd Market Cap28139076.000-1%28407067.20034113046.500-17%31299138.900-9%52160020.560-46%48256282.080-41%
Usd Price Per Share0.287-1%0.2900.348-17%0.320-9%0.533-46%0.493-41%
Usd Profit---727593.600-354289.200-51%-948958.800+30%-610511.040-16%-568584.932-22%
Usd Revenue--2545300.8003325836.000-23%2623094.400-3%2521310.640+1%1814946.122+40%
Usd Total Gains Per Share---0.007-0.003-54%-0.009+31%0.001-923%0.001-1064%
 EOD+4 -4MRQTTM+8 -26YOY+18 -165Y+13 -2110Y+13 -21

3.2. Fundamental Score

Let's check the fundamental score of Organoclick AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.669
Price to Book Ratio (EOD)Between0-15.777
Net Profit Margin (MRQ)Greater than0-0.286
Operating Margin (MRQ)Greater than0-0.221
Quick Ratio (MRQ)Greater than10.350
Current Ratio (MRQ)Greater than10.814
Debt to Asset Ratio (MRQ)Less than10.646
Debt to Equity Ratio (MRQ)Less than12.183
Return on Equity (MRQ)Greater than0.15-0.179
Return on Assets (MRQ)Greater than0.05-0.053
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Organoclick AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.631
Ma 20Greater thanMa 503.280
Ma 50Greater thanMa 1003.100
Ma 100Greater thanMa 2003.163
OpenGreater thanClose3.300
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets150,749
Total Liabilities97,342
Total Stockholder Equity44,581
 As reported
Total Liabilities 97,342
Total Stockholder Equity+ 44,581
Total Assets = 150,749

Assets

Total Assets150,749
Total Current Assets68,892
Long-term Assets81,857
Total Current Assets
Cash And Cash Equivalents 10,737
Net Receivables 18,930
Inventory 36,688
Other Current Assets 2,537
Total Current Assets  (as reported)68,892
Total Current Assets  (calculated)68,892
+/-0
Long-term Assets
Property Plant Equipment 36,155
Goodwill 16,794
Long-term Assets Other 24,921
Long-term Assets  (as reported)81,857
Long-term Assets  (calculated)77,870
+/- 3,987

Liabilities & Shareholders' Equity

Total Current Liabilities84,684
Long-term Liabilities12,658
Total Stockholder Equity44,581
Total Current Liabilities
Short-term Debt 36,924
Accounts payable 14,559
Other Current Liabilities 33,201
Total Current Liabilities  (as reported)84,684
Total Current Liabilities  (calculated)84,684
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)12,658
Long-term Liabilities  (calculated)0
+/- 12,658
Total Stockholder Equity
Common Stock980
Retained Earnings -263,495
Accumulated Other Comprehensive Income 37
Other Stockholders Equity 307,059
Total Stockholder Equity (as reported)44,581
Total Stockholder Equity (calculated)44,581
+/-0
Other
Cash and Short Term Investments 10,737
Common Stock Shares Outstanding 97,950
Liabilities and Stockholders Equity 150,749
Net Debt 37,700
Net Working Capital -15,792
Short Long Term Debt Total 48,437



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-31
> Total Assets 
30,330
0
0
19,925
24,592
90,145
96,276
87,571
82,313
79,046
82,404
65,708
83,785
83,843
90,461
122,956
101,778
104,459
111,007
92,374
88,103
125,894
130,209
206,533
173,199
167,234
181,981
160,847
152,802
166,020
230,233
194,642
188,386
189,934
191,231
177,351
162,856
178,255
168,984
162,226
150,749
150,749162,226168,984178,255162,856177,351191,231189,934188,386194,642230,233166,020152,802160,847181,981167,234173,199206,533130,209125,89488,10392,374111,007104,459101,778122,95690,46183,84383,78565,70882,40479,04682,31387,57196,27690,14524,59219,9250030,330
   > Total Current Assets 
27,505
0
0
16,010
11,802
74,794
79,371
68,138
58,167
51,981
52,238
34,538
33,925
33,106
38,859
66,958
44,657
47,015
53,811
34,536
30,991
41,244
46,710
123,787
91,159
85,892
101,555
69,265
58,922
63,972
128,120
92,716
82,484
83,195
85,794
71,673
75,943
91,803
83,895
79,719
68,892
68,89279,71983,89591,80375,94371,67385,79483,19582,48492,716128,12063,97258,92269,265101,55585,89291,159123,78746,71041,24430,99134,53653,81147,01544,65766,95838,85933,10633,92534,53852,23851,98158,16768,13879,37174,79411,80216,0100027,505
       Cash And Cash Equivalents 
20,738
0
0
4,448
3,283
53,157
54,506
49,045
40,349
32,171
27,937
16,422
10,040
2,997
7,151
41,041
22,265
11,250
14,403
6,049
6,122
8,379
8,458
4,666
61,150
49,898
58,103
38,076
32,028
17,153
73,714
48,560
34,248
16,269
14,279
12,968
15,204
10,656
12,307
9,650
10,737
10,7379,65012,30710,65615,20412,96814,27916,26934,24848,56073,71417,15332,02838,07658,10349,89861,1504,6668,4588,3796,1226,04914,40311,25022,26541,0417,1512,99710,04016,42227,93732,17140,34949,04554,50653,1573,2834,4480020,738
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13,876
16,957
25,217
15,357
11,025
24,933
29,677
16,460
11,983
26,965
29,215
19,429
19,216
40,041
30,763
32,554
18,930
18,93032,55430,76340,04119,21619,42929,21526,96511,98316,46029,67724,93311,02515,35725,21716,95713,876000000000000000000000000
       Inventory 
2,757
0
0
5,192
3,591
10,941
13,054
12,128
10,237
8,246
10,324
7,980
10,088
12,688
10,744
10,303
10,452
15,277
15,429
14,619
14,452
17,053
16,664
15,891
15,121
17,492
14,552
12,587
14,331
19,904
22,198
25,884
32,391
35,736
38,432
35,662
41,524
41,105
38,971
37,514
36,688
36,68837,51438,97141,10541,52435,66238,43235,73632,39125,88422,19819,90414,33112,58714,55217,49215,12115,89116,66417,05314,45214,61915,42915,27710,45210,30310,74412,68810,0887,98010,3248,24610,23712,12813,05410,9413,5915,192002,757
       Other Current Assets 
4,011
0
0
6,371
4,928
10,697
11,811
6,965
7,581
11,564
13,977
10,136
13,797
17,421
20,964
15,614
11,940
20,488
23,979
13,868
10,417
15,812
21,588
103,230
14,888
18,502
28,900
18,602
12,563
26,915
32,208
18,272
15,845
-1
33,083
3,614
-1
1
1,854
1
2,537
2,53711,8541-13,61433,083-115,84518,27232,20826,91512,56318,60228,90018,50214,888103,23021,58815,81210,41713,86823,97920,48811,94015,61420,96417,42113,79710,13613,97711,5647,5816,96511,81110,6974,9286,371004,011
   > Long-term Assets 
2,824
0
0
3,915
12,791
15,350
16,904
19,433
24,146
27,065
30,167
31,170
49,860
50,737
51,602
55,998
57,121
57,444
57,197
57,838
57,113
84,650
83,499
82,746
82,040
81,342
80,427
91,582
93,881
102,048
102,113
101,926
105,902
106,740
105,437
105,678
86,913
86,452
85,088
82,508
81,857
81,85782,50885,08886,45286,913105,678105,437106,740105,902101,926102,113102,04893,88191,58280,42781,34282,04082,74683,49984,65057,11357,83857,19757,44457,12155,99851,60250,73749,86031,17030,16727,06524,14619,43316,90415,35012,7913,915002,824
       Property Plant Equipment 
1,173
0
0
2,178
9,336
10,707
11,325
12,448
15,238
17,629
19,836
20,727
21,954
22,085
22,579
22,892
22,505
22,020
20,979
21,465
20,673
47,571
45,455
43,737
42,418
41,012
39,322
49,535
49,876
57,130
55,680
54,419
58,564
59,841
58,232
57,886
43,633
42,281
40,037
37,374
36,155
36,15537,37440,03742,28143,63357,88658,23259,84158,56454,41955,68057,13049,87649,53539,32241,01242,41843,73745,45547,57120,67321,46520,97922,02022,50522,89222,57922,08521,95420,72719,83617,62915,23812,44811,32510,7079,3362,178001,173
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,794
16,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,79416,7940000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,512
15,246
15,892
16,110
16,155
16,501
17,465
18,050
18,599
19,595
20,375
21,385
22,183
24,099
25,575
26,590
26,331
25,976
26,285
26,766
22,255
22,948
23,733
23,945
0
023,94523,73322,94822,25526,76626,28525,97626,33126,59025,57524,09922,18321,38520,37519,59518,59918,05017,46516,50116,15516,11015,89215,24614,5120000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,198
17,226
17,749
18,056
19,554
20,352
21,181
21,932
21,835
-1
21,937
22,481
1,091
1,289
1
-1
0
0-111,2891,09122,48121,937-121,83521,93221,18120,35219,55418,05617,74917,22617,198000000000000000000000000
> Total Liabilities 
8,694
0
0
10,007
17,964
18,860
24,979
20,712
22,832
26,709
35,591
25,984
42,308
49,383
58,448
58,893
47,492
55,056
62,526
50,538
53,305
94,046
98,647
94,643
70,728
69,818
83,691
68,132
69,858
88,279
90,373
74,734
80,657
85,680
94,499
89,375
95,300
111,457
103,874
101,163
97,342
97,342101,163103,874111,45795,30089,37594,49985,68080,65774,73490,37388,27969,85868,13283,69169,81870,72894,64398,64794,04653,30550,53862,52655,05647,49258,89358,44849,38342,30825,98435,59126,70922,83220,71224,97918,86017,96410,007008,694
   > Total Current Liabilities 
8,694
0
0
10,007
14,034
14,366
20,337
15,661
18,263
22,179
31,127
21,730
30,757
33,948
42,057
42,937
32,481
39,906
50,009
37,455
38,185
59,374
66,778
65,544
46,751
47,375
63,543
43,510
45,158
59,468
63,431
49,432
54,380
61,199
71,817
64,417
75,422
92,929
87,277
86,518
84,684
84,68486,51887,27792,92975,42264,41771,81761,19954,38049,43263,43159,46845,15843,51063,54347,37546,75165,54466,77859,37438,18537,45550,00939,90632,48142,93742,05733,94830,75721,73031,12722,17918,26315,66120,33714,36614,03410,007008,694
       Short-term Debt 
0
0
0
0
686
789
5,502
9,610
8,617
8,671
8,893
8,556
9,783
7,958
9,885
13,382
12,705
13,170
19,924
19,612
21,202
28,778
29,909
35,857
23,649
19,030
25,976
18,808
14,788
19,081
19,492
17,944
28,685
18,764
24,913
26,253
42,143
29,910
29,495
29,385
36,924
36,92429,38529,49529,91042,14326,25324,91318,76428,68517,94419,49219,08114,78818,80825,97619,03023,64935,85729,90928,77821,20219,61219,92413,17012,70513,3829,8857,9589,7838,5568,8938,6718,6179,6105,5027896860000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,133
11,375
18,223
11,466
7,481
10,671
11,356
10,106
20,306
10,372
16,065
16,984
33,006
20,663
20,468
20,600
0
020,60020,46820,66333,00616,98416,06510,37220,30610,10611,35610,6717,48111,46618,22311,37516,133000000000000000000000000
       Accounts payable 
1,360
0
0
2,098
2,132
10,059
4,750
2,485
3,788
3,643
9,087
4,022
8,451
14,574
11,337
8,959
7,781
9,248
10,679
6,423
4,793
10,332
10,831
9,572
5,988
9,975
13,291
8,450
13,854
15,659
17,455
12,696
13,365
16,305
15,256
11,507
15,478
16,474
14,593
14,312
14,559
14,55914,31214,59316,47415,47811,50715,25616,30513,36512,69617,45515,65913,8548,45013,2919,9755,9889,57210,83110,3324,7936,42310,6799,2487,7818,95911,33714,5748,4514,0229,0873,6433,7882,4854,75010,0592,1322,098001,360
       Other Current Liabilities 
7,334
0
0
7,909
11,216
3,519
10,085
3,566
5,858
9,865
13,147
9,152
12,523
11,416
20,835
20,596
11,995
17,488
19,406
11,420
12,190
20,264
26,038
20,115
17,114
18,370
24,276
16,252
16,516
24,728
26,484
18,792
10,305
26,130
31,648
26,657
17,801
46,545
33,201
31,311
33,201
33,20131,31133,20146,54517,80126,65731,64826,13010,30518,79226,48424,72816,51616,25224,27618,37017,11420,11526,03820,26412,19011,42019,40617,48811,99520,59620,83511,41612,5239,15213,1479,8655,8583,56610,0853,51911,2167,909007,334
   > Long-term Liabilities 
0
0
0
0
3,931
4,494
4,642
5,051
4,569
4,530
4,464
4,254
11,551
15,435
16,391
15,956
15,011
15,150
12,517
13,083
15,120
34,672
31,869
29,099
23,977
22,443
20,148
24,622
24,700
28,811
26,942
25,302
26,277
24,481
22,682
24,958
19,878
18,528
16,597
14,645
12,658
12,65814,64516,59718,52819,87824,95822,68224,48126,27725,30226,94228,81124,70024,62220,14822,44323,97729,09931,86934,67215,12013,08312,51715,15015,01115,95616,39115,43511,5514,2544,4644,5304,5695,0514,6424,4943,9310000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,302
23,345
27,307
25,358
23,727
24,854
23,048
21,236
23,372
18,535
17,178
15,179
0
0
0015,17917,17818,53523,37221,23623,04824,85423,72725,35827,30723,34524,302000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
285
303
320
319
355
504
584
575
423
433
446
586
343
0
0
1,437
0
01,43700343586446433423575584504355319320303285000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,971
13,285
13,815
14,187
15,532
16,327
17,117
17,809
17,622
17,553
17,811
18,249
16,598
0
0
18,162
0
018,1620016,59818,24917,81117,55317,62217,80917,11716,32715,53214,18713,81513,28512,971000000000000000000000000
> Total Stockholder Equity
5,835
0
0
-3,792
-12,072
53,370
53,218
49,333
42,341
34,689
28,405
20,986
21,755
15,464
11,444
42,306
32,344
26,913
25,187
18,737
12,092
8,935
7,211
87,279
77,730
71,915
70,565
63,928
54,080
47,755
108,361
111,852
100,325
96,204
87,736
78,983
58,777
58,151
55,862
52,147
44,581
44,58152,14755,86258,15158,77778,98387,73696,204100,325111,852108,36147,75554,08063,92870,56571,91577,73087,2797,2118,93512,09218,73725,18726,91332,34442,30611,44415,46421,75520,98628,40534,68942,34149,33353,21853,370-12,072-3,792005,835
   Common Stock
275
0
0
275
550
661
671
671
671
671
671
671
680
685
685
745
745
745
745
745
745
745
158,655
921
921
921
921
921
921
921
980
980
980
980
980
980
980
980
980
980
980
980980980980980980980980980980980921921921921921921921158,65574574574574574574574568568568067167167167167167166155027500275
   Retained Earnings -263,495-255,928-252,214-249,924-249,295-229,088-220,335-211,864-207,746-196,218-203,352-196,963-190,637-180,790-174,152-172,804-166,991-157,574-151,481-149,757-146,600-139,964-133,514-131,783-126,354-116,467-108,644-104,508-99,244-90,910-83,428-75,945-68,293-61,272-57,353-53,476-48,333-9,62700-10,384
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
243,764
243,764
243,764
243,764
243,764
243,764
310,701
307,059
307,059
307,059
307,059
307,059
307,059
307,059
307,059
0
0
00307,059307,059307,059307,059307,059307,059307,059307,059310,701243,764243,764243,764243,764243,764243,764000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000
   Other Stockholders Equity 
15,943
0
0
5,560
35,711
106,186
109,900
109,934
109,963
109,963
111,162
111,225
120,319
119,287
119,403
158,028
157,953
157,951
157,956
157,956
157,947
157,947
37
243,932
243,800
243,798
243,796
243,797
243,796
243,797
310,733
307,090
307,091
307,088
307,091
307,091
307,092
307,057
307,058
307,058
307,059
307,059307,058307,058307,057307,092307,091307,091307,088307,091307,090310,733243,797243,796243,797243,796243,798243,800243,93237157,947157,947157,956157,956157,951157,953158,028119,403119,287120,319111,225111,162109,963109,963109,934109,900106,18635,7115,5600015,943



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue145,871
Cost of Revenue-110,481
Gross Profit35,39035,390
 
Operating Income (+$)
Gross Profit35,390
Operating Expense-43,878
Operating Income-8,488-8,488
 
Operating Expense (+$)
Research Development6,651
Selling General Administrative14,245
Selling And Marketing Expenses24,986
Operating Expense43,87845,882
 
Net Interest Income (+$)
Interest Income91
Interest Expense-4,960
Other Finance Cost-413
Net Interest Income-4,456
 
Pretax Income (+$)
Operating Income-8,488
Net Interest Income-4,456
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-14,087-2,889
EBIT - interestExpense = -13,448
-15,703
-10,812
Interest Expense4,960
Earnings Before Interest and Taxes (EBIT)-8,488-9,127
Earnings Before Interest and Taxes (EBITDA)6,592
 
After tax Income (+$)
Income Before Tax-14,087
Tax Provision--312
Net Income From Continuing Ops-26,920-13,775
Net Income-15,772
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses154,359
Total Other Income/Expenses Net-5,5994,456
 

Technical Analysis of Organoclick
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Organoclick. The general trend of Organoclick is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Organoclick's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Organoclick AB.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 3.6 < 3.84 < 3.88.

The bearish price targets are: 3.15 > 3.15 > 3.12.

Tweet this
Organoclick AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Organoclick AB. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Organoclick AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Organoclick AB. The current macd is 0.02663651.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Organoclick price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Organoclick. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Organoclick price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Organoclick AB Daily Moving Average Convergence/Divergence (MACD) ChartOrganoclick AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Organoclick AB. The current adx is 52.21.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Organoclick shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Organoclick AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Organoclick AB. The current sar is 3.80235034.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Organoclick AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Organoclick AB. The current rsi is 48.63. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Organoclick AB Daily Relative Strength Index (RSI) ChartOrganoclick AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Organoclick AB. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Organoclick price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Organoclick AB Daily Stochastic Oscillator ChartOrganoclick AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Organoclick AB. The current cci is -86.80171885.

Organoclick AB Daily Commodity Channel Index (CCI) ChartOrganoclick AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Organoclick AB. The current cmo is -8.47464952.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Organoclick AB Daily Chande Momentum Oscillator (CMO) ChartOrganoclick AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Organoclick AB. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Organoclick AB Daily Williams %R ChartOrganoclick AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Organoclick AB.

Organoclick AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Organoclick AB. The current atr is 0.22429675.

Organoclick AB Daily Average True Range (ATR) ChartOrganoclick AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Organoclick AB. The current obv is -3,888,943.

Organoclick AB Daily On-Balance Volume (OBV) ChartOrganoclick AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Organoclick AB. The current mfi is 64.61.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Organoclick AB Daily Money Flow Index (MFI) ChartOrganoclick AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Organoclick AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-13MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-21CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Organoclick AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Organoclick AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.631
Ma 20Greater thanMa 503.280
Ma 50Greater thanMa 1003.100
Ma 100Greater thanMa 2003.163
OpenGreater thanClose3.300
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Organoclick with someone you think should read this too:
  • Are you bullish or bearish on Organoclick? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Organoclick? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Organoclick AB

I send you an email if I find something interesting about Organoclick AB.


Comments

How you think about this?

Leave a comment

Stay informed about Organoclick AB.

Receive notifications about Organoclick AB in your mailbox!